How parametric insurance works, what rate-on-line ranges look like in the US market, how basis risk actually shows up in claims, and when index-trigger coverage beats traditional indemnity insurance for hurricane, earthquake, drought, and heat risk.
A practical breakdown of MDL 3080, the insulin pricing and rebate litigation consolidated in federal court in New Jersey against Eli Lilly, Novo Nordisk, Sanofi, and PBMs CVS Caremark, Express Scripts, and OptumRx. Covers who qualifies to file, how the rebate and spread pricing scheme actually works, the FTC's separate track, settlement timing, and how to evaluate a claim before you sign anything.
BPOP (Popular, Inc.) 2026 stock outlook covering Banco Popular's near-monopoly grip on Puerto Rico banking, CET1 capital normalization and buyback acceleration, mainland US expansion, net interest margin sensitivity, and single-island concentration risk.
A deep-dive Enovis (ENOV) stock outlook for 2026 covering the Prevention & Recovery bracing business, the Reconstructive implant segment, the bolt-on M&A strategy built around the LimaCorporate deal, leverage risk, competition from Stryker, Zimmer Biomet and Smith+Nephew, and what to watch in coming quarters.
Kontoor Brands (KTB) stock outlook 2026: a deep, qualitative look at how Wrangler and Lee's workwear heritage funds steady dividends, why the Helly Hansen acquisition matters, and how KTB stacks up against Levi's, VF, and PVH.
A deep-dive MNDY (monday.com) stock outlook for 2026 covering the Work OS platform moat, the product-led growth engine, the shift from per-seat subscriptions to usage-based AI credit pricing, competitive dynamics against Asana, Atlassian and Smartsheet, and the SaaS metrics — NRR and Rule of 40 — that actually tell you whether the pivot is working.
RRR (Red Rock Resorts) stock outlook 2026: a deep dive into the Las Vegas locals casino model, the Durango and land-bank growth pipeline, the Fertitta family's UP-C control structure, leverage risk, and how RRR really differs from Strip-facing casino operators.
Kinross Gold (KGC) stock outlook for 2026, covering the post-Russia portfolio, AISC cost structure and gold-price leverage, the Great Bear growth project, and how KGC stacks up against Newmont, Barrick, and Agnico Eagle.
PPL Corporation (PPL) stock outlook 2026: how Pennsylvania and Kentucky grid capex, PJM data center load growth, rate base economics, and a post-cut dividend rebuild shape the investment case for this regulated electric utility.
CRH plc (NYSE: CRH) stock outlook for 2026: a deep qualitative look at its vertically integrated aggregates, cement, and asphalt business, its 2023 move to a New York primary listing, exposure to US infrastructure spending and data-center construction, and how it compares against Vulcan Materials and Martin Marietta.
DY (Dycom Industries) stock outlook for 2026: the specialty contracting business model behind fiber and broadband buildouts, AT&T customer concentration risk, the BEAD rural broadband subsidy timeline, emerging data center fiber demand, and how Dycom stacks up against Quanta Services and MasTec.
Kodiak Gas Services (KGS) stock outlook 2026: a deep, qualitative look at the contract compression business model, the CSI Compressco merger, Permian associated-gas demand, AI data center power tailwinds, leverage risk, and the dividend, written for US investors weighing an infrastructure-style energy stock.
Sundo Electric (KRX: 007610) 2026 stock outlook for US investors. We break down its switchgear, vacuum circuit breaker, and GIS business, how it differs from Korea's large-cap grid equipment exporters, access and FX considerations for US brokerage accounts, and the risks worth weighing before buying a small-cap KRX name.
KBI Dongyang Steel Pipe (formerly Dongyang Steel Pipe, KOSPI: 008970) stock outlook 2026 for US-based investors. Covers the structural pipe, oil and gas pipeline, and offshore wind substructure pile business, steel-cost margin cycles, Korean peer comparison, KRX access, dividend withholding, and currency risk for a US portfolio.
A qualitative 2026 stock outlook for Kukje Pharma (KRX 002720), a Korean generics and OTC pharmaceutical maker known for eye-care drops, that has diversified into face masks and cosmetics. We cover its pharmacy-channel moat, Korea's drug-price reset risk, peer comparisons against Yuhan, Daewoong and Hanmi, and how global investors should frame this small-cap KOSPI healthcare-consumer hybrid.
KT Genie Music (formerly Genie Music, KOSDAQ 043610) stock outlook 2026. A deep look at Korea's number-two music streaming platform, its KT Corporation ownership, royalty-driven margin structure, competition from Melon and YouTube Music, and what US investors should know before buying a Korean small-cap streamer.
Saeron Automotive (KRX: 075180) stock outlook for 2026. A qualitative deep dive into the Korean brake pad and lining maker's Hyundai/Kia OEM concentration, raw material cost pressure, aftermarket resilience, and how EV regenerative braking is reshaping friction material demand.
Hanil Forging Industrial (KRX: 024740) stock outlook 2026: how a small KOSDAQ forging company ended up supplying both marine engine crankshafts to Korea's big three shipyards and precision-forged 155mm artillery shell bodies to the K-defense export boom, plus the risks, peer comparison, and KRW exposure foreign investors need to weigh.
Dongbu Construction (KRX: 005960) 2026 stock analysis for international investors: the Centreville housing brand, civil-engineering and plant segments, the lasting impact of its 2015-2016 corporate workout, PF-risk exposure in Korea's construction sector, and a peer comparison against other Korean mid-tier builders.
Korea Real Estate Trust (KOREIT, KRX: 034830) stock outlook for 2026, covering its borrowed-money land trust model, exposure to Korea's real estate project-financing crisis, private-equity ownership, dividend durability, and what US investors need to know about accessing and taxing a KRX-listed name.
GS Global (001250) stock outlook 2026: a qualitative look at this GS Group trading house's low-margin commodity business, its pivot into power generation, used-car exports and battery materials, the Korea discount, and how US-based investors can access KOSPI shares.
YG-1 (KRX: 019210) stock outlook for 2026. A qualitative deep dive into the Korean cutting-tool maker's consumable-replacement business model, its 80% export mix across automotive, semiconductor and aerospace end markets, tungsten carbide input-cost risk, and what a US investor actually needs to know to hold a KOSDAQ-listed small-cap.
A practical breakdown of the new $6,000 senior bonus deduction for taxpayers 65 and older under the 2025 tax law, including the income phase-out ranges, how it stacks on top of the standard deduction, why it is not the same as tax-free Social Security, and filing mistakes to avoid before the 2028 sunset.
The OBBBA (Pub.L.119-21, effective July 4, 2025) raised the SALT deduction cap to $40,000 for 2025 and $40,400 for 2026, rising 1% annually through 2029. But a 30% phase-down starts at $500,000 MAGI and the cap reverts to $10,000 in 2030. Here's the practical breakdown.